Results 311 to 320 of about 2,301,317 (358)

Leukoreduction of blood components

Current Opinion in Hematology, 2002
During the past year, blood component therapy witnessed two quite contradictory trends in the area of leukoreduction. On the one hand, the year saw widespread forced implementation of leukoreduction by several national blood suppliers, including the American Red Cross, who refused to sell hospitals nonleukoreduced blood.
openaire   +2 more sources

Blood component therapy

Clinics in Haematology, 1978
T A, Lister, R A, Yankee
openaire   +2 more sources

Social determinants of health and US cancer screening interventions: A systematic review

Ca-A Cancer Journal for Clinicians, 2023
Ariella R Korn
exaly  

Blood component recalls

Transfusion, 1999
openaire   +2 more sources

Blood component safety

Transfusion and Apheresis Science, 2001
openaire   +2 more sources

The Affordable Care Act and access to care across the cancer control continuum: A review at 10 years

Ca-A Cancer Journal for Clinicians, 2020
Jingxuan Zhao, Ziling Mao, Stacey A Fedewa   +2 more
exaly  

Illuminating blood components

Transfusion and Apheresis Science, 2009
openaire   +2 more sources

Blood and Component Therapy

Nursing Clinics of North America, 1980
M E, Woods, I, Mazza
openaire   +2 more sources

Micrometastatic cancer cells in lymph nodes, bone marrow, and blood: Clinical significance and biologic implications

Ca-A Cancer Journal for Clinicians, 2014
William W Tseng
exaly  

Blood Components

2006
openaire   +1 more source